These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 33830317)

  • 1. Predictor analysis of 1-year restenosis after percutaneous transluminal angioplasty for femoropopliteal stenotic lesions using intravascular ultrasound.
    Kakizaki S; Kozuki A; Kijima Y; Nagoshi R; Fujiwara R; Shibata H; Suzuki A; Fujimoto D; Kyo S; Masuko E; Miyata T; Shite J
    Heart Vessels; 2021 Nov; 36(11):1661-1669. PubMed ID: 33830317
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravascular ultrasound measurements after drug-eluting stent placement in femoropopliteal lesions: determining predictors of restenosis.
    Mori S; Hirano K; Nakano M; Muramatsu T; Tsukahara R; Ito Y; Ishimori H
    J Endovasc Ther; 2015 Jun; 22(3):341-9. PubMed ID: 25862363
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of Baseline and Postprocedural Intravascular Ultrasound Findings on 1-Year Primary Patency After Drug-Coated Balloon Treatment of Femoropopliteal Lesions.
    Horie K; Tanaka A; Taguri M; Inoue N
    J Endovasc Ther; 2022 Feb; 29(1):66-75. PubMed ID: 34781756
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of oral cilostazol 100 mg BID on long-term patency after percutaneous transluminal angioplasty in patients with femoropopliteal disease undergoing hemodialysis: a retrospective chart review in Japanese patients.
    Ishii H; Kumada Y; Toriyama T; Aoyama T; Takahashi H; Tanaka M; Kamoi D; Kawamura Y; Yamada S; Hayashi M; Yasuda Y; Yuzawa Y; Maruyama S; Matsuo S; Matsubara T; Murohara T
    Clin Ther; 2010 Jan; 32(1):24-33. PubMed ID: 20171408
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of Scoring Balloons on Percutaneous Transluminal Angioplasty Outcomes in Femoropopliteal Lesions.
    Horie K; Tanaka A; Taguri M; Inoue N
    J Endovasc Ther; 2020 Jun; 27(3):481-491. PubMed ID: 32249658
    [No Abstract]   [Full Text] [Related]  

  • 6. Differences in Intravascular Ultrasound Measurement Values Between Treatment Modalities for Restenosis in Femoropopliteal Lesions.
    Aihara H; Higashitani M; Takimura H; Tobita K; Jujo K; Hozawa K; Yamaguchi T; Iwata Y; Tokuyama H; Sakurai M; Murata N; Fujimoto Y; Kikuchi A; Koganei H; Sato A; Noguchi Y; Ieda M
    Circ J; 2020 Jul; 84(8):1320-1329. PubMed ID: 32581151
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravascular ultrasound predictors of restenosis after balloon angioplasty of the femoropopliteal artery.
    van der Lugt A; Gussenhoven EJ; Pasterkamp G; Stijnen T; Reekers JA; van den Berg FG; Tielbeek AV; Seelen JL; Pieterman H
    Eur J Vasc Endovasc Surg; 1998 Aug; 16(2):110-9. PubMed ID: 9728429
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictability and usefulness of intravascular ultrasound-guided angioplasty in patients with femoropopliteal lesions.
    Jiang J; Xu W
    Int Angiol; 2022 Feb; 41(1):74-81. PubMed ID: 34825800
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug-Eluting Stent vs Percutaneous Transluminal Angioplasty for Treatment of Femoropopliteal In-Stent Restenosis: Results From a Retrospective 1-Year Multicenter Study.
    Murata N; Takahara M; Soga Y; Nakano M; Yamauchi Y; Zen K; Kawasaki D; Yokoi H; Tosaka A; Tanaka N; Iida O
    J Endovasc Ther; 2016 Aug; 23(4):642-7. PubMed ID: 27099284
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of IVUS-Derived Vessel Size on Midterm Outcomes After Stent Implantation in Femoropopliteal Lesions.
    Miki K; Fujii K; Tanaka T; Yanaka K; Yoshihara N; Nishimura M; Sumiyoshi A; Horimatsu T; Imanaka T; Fukunaga M; Akahori H; Masuyama T; Ishihara M
    J Endovasc Ther; 2020 Feb; 27(1):77-85. PubMed ID: 31948376
    [No Abstract]   [Full Text] [Related]  

  • 11. Intraarterial (192)Ir high-dose-rate brachytherapy for prophylaxis of restenosis after femoropopliteal percutaneous transluminal angioplasty: the prospective randomized Vienna-2-trial radiotherapy parameters and risk factors analysis.
    Pokrajac B; Pötter R; Maca T; Fellner C; Mittlböck M; Ahmadi R; Seitz W; Minar E
    Int J Radiat Oncol Biol Phys; 2000 Nov; 48(4):923-31. PubMed ID: 11072147
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravascular Ultrasound-Derived Stent Dimensions as Predictors of Angiographic Restenosis Following Nitinol Stent Implantation in the Superficial Femoral Artery.
    Miki K; Fujii K; Kawasaki D; Shibuya M; Fukunaga M; Imanaka T; Tamaru H; Sumiyoshi A; Nishimura M; Horimatsu T; Saita T; Okada K; Kimura T; Honda Y; Fitzgerald PJ; Masuyama T; Ishihara M
    J Endovasc Ther; 2016 Jun; 23(3):424-32. PubMed ID: 27044270
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of Postoperative Lumen Gain on the Reduction of Restenosis Risk after Endovascular Treatment using Drug-coated Balloon for Femoropopliteal Lesions Assessed by Intravascular Ultrasound.
    Horie K; Takahara M; Nakama T; Tanaka A; Tobita K; Hayakawa N; Mori S; Iwata Y; Suzuki K
    J Atheroscler Thromb; 2023 Sep; 30(9):1142-1151. PubMed ID: 36436877
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Comparative Cost-Effectiveness Analysis of Percutaneous Transluminal Angioplasty With Optional Stenting and Femoropopliteal Bypass Surgery for Medium-Length TASC II B and C Femoropopliteal Lesions.
    Vossen RJ; Philipszoon PC; Vahl AC; Montauban van Swijndregt AD; Leijdekkers VJ; Balm R
    J Endovasc Ther; 2019 Apr; 26(2):172-180. PubMed ID: 30898070
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lumen Gain After Endovascular Therapy in Calcified Superficial Femoral Artery Occlusive Disease Assessed by Intravascular Ultrasound (CODE Study).
    Fujihara M; Kozuki A; Tsubakimoto Y; Takahara M; Shintani Y; Fukunaga M; Iwasaki Y; Nakama T; Yokoi Y
    J Endovasc Ther; 2019 Jun; 26(3):322-330. PubMed ID: 30873909
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Paclitaxel-Eluting Balloon Versus Standard Balloon Angioplasty in In-Stent Restenosis of the Superficial Femoral and Proximal Popliteal Artery: 1-Year Results of the PACUBA Trial.
    Kinstner CM; Lammer J; Willfort-Ehringer A; Matzek W; Gschwandtner M; Javor D; Funovics M; Schoder M; Koppensteiner R; Loewe C; Ristl R; Wolf F
    JACC Cardiovasc Interv; 2016 Jul; 9(13):1386-92. PubMed ID: 27388828
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of intravascular ultrasound in femoropopliteal stenting for peripheral artery disease with TASC II class A to C lesions.
    Iida O; Takahara M; Soga Y; Suzuki K; Hirano K; Kawasaki D; Shintani Y; Suematsu N; Yamaoka T; Nanto S; Uematsu M
    J Endovasc Ther; 2014 Aug; 21(4):485-92. PubMed ID: 25101575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plaque area increase and vascular remodeling contribute to lumen area change after percutaneous transluminal angioplasty of the femoropopliteal artery: an intravascular ultrasound study.
    van Lankeren W; Gussenhoven EJ; Honkoop J; Stijnen T; van Overhagen H; Wittens CH; Kranendonk SE; van Sambeek MR; van der Lugt A
    J Vasc Surg; 1999 Mar; 29(3):430-41. PubMed ID: 10069907
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Femoropopliteal Arterial Dissections Post Flex Vessel Prep and Adjunctive Angioplasty: Results of the Flex iDissection Study.
    Shammas NW; Shammas WJ; Jones-Miller S; Radaideh Q; Shammas GA
    J Invasive Cardiol; 2019 May; 31(5):121-126. PubMed ID: 31034434
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Angioplasty and elective stenting of de novo versus recurrent femoropopliteal lesions: 1-year follow-up.
    Schillinger M; Mlekusch W; Haumer M; Sabeti S; Ahmadi R; Minar E
    J Endovasc Ther; 2003 Apr; 10(2):288-97. PubMed ID: 12877612
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.